Industry involvement in scientific studies on SSRI's

What is this about?

This case is about scientific fraud in research concerning psychopharmacology. Specifically, it is about the use of the selective serotonin reuptake inhibitor (SSRI) group of antidepressants that has the potential to trigger suicidality in a subgroup of patients. This is a factual case, linked to companies' abilties to keep clinical trial data out of the public domain.